Építés alatt – nem éles oldal
Belépés
LeállítvaFázis nélkül

Combined Aerobic and Resistance Exercise Training in Metastatic Renal Cell Carcinoma

A legfontosabb adatok

Ki végzi
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Hol
Baltimore (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Leállítva
Résztvevők
2 fő vett részt
Kezdés
2022. febr. 17.
Befejezés
2024. ápr. 1.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • Combined Aerobic and Resistance Exercise Training
A regiszteradat frissítve
2024. április 4.
Miért állt le
Study terminated due to lack of funding

Ki vehet részt

Életkor
18 év – 99 év
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 15 feltétel megnézéseKevesebb

Ki vehet részt

  • Histologically confirmed diagnosis of RCC
  • Patients being treated with standard of Programmed cell death protein 1 (anti-PD-1) or anti-PD-L1 immune-checkpoint inhibitor-containing standard of care regimen including patients who are about to start treatment or have been on treatment for a maximum of 4 weeks prior to signing consent
  • Metastatic Measurable disease, as defined by RECIST 1.1
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 with a life expectancy ≥ six months
  • Physically able to enroll in the exercise program as determined by the treating medical oncologist and after review by Physical medicine and rehabilitation physicians at Johns Hopkins
  • Adequate bone marrow reserve and organ function measured within 28 days prior to administration of study treatment with the following key parameters:
  • Hematological:; Absolute neutrophil count ≥ 1.5 × 109/L; Platelets ≥ 100 × 109/L; Hemoglobin≥ 9.0 g/dL
  • Renal:; Serum Creatinine ≤ 1.5 x the upper limit of normal (ULN) or Calculated Creatinine clearance ≥ 30mL/min
  • Hepatic:; Total bilirubin ≤ 1.5 x ULN (Patients with known Gilbert disease who have serum bilirubin level ≤ 3 x ULN may be enrolled); Serum Aspartate aminotransferase (AST) and serum Alanine aminotransferase (ALT) ≤ 2.5 x ULN (For patients with documented liver metastases AST and/or ALT ≤ 5 x ULN)

Ki nem vehet részt

  • Known underlying uncontrolled brain metastatic lesions requires steroids therapy and/or radiotherapy
  • Major surgery within four weeks prior to enrollment
  • Radiotherapy for RCC 28 days prior to week 1 day 1
  • History of underlying cardiovascular, respiratory, musculoskeletal disease or joint problems that preclude moderate physical activity
  • The presence of bone metastasis in the spine, pelvis, and lower limbs
  • Currently physically active or moderately active as determined by Leisure Score Index of Godin Leisure-Time Exercise Questionnaire (GSLTPAQ)

Helyszínek itt: Egyesült Államok

  • Johns Hopkins University/Sidney Kimmel Cancer CenterBaltimore, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

The trial studies the effects of personalized home-based aerobic and resistance exercises on quality of life, changes in physical activity levels, and the change in inflammatory myokines with the exercise intervention in Interleukin 6 (IL-6), C-reactive Protein (CRP), Leptin, Transforming growth factor beta (TGF-beta), and Interferon (INF) gamma.

A vizsgálat csoportja

  • Supportive CareA vizsgált kezelés

    Patients with metastatic renal cell carcinoma (RCC) who are receiving immune-checkpoint inhibitor therapy

    Kezelés: Combined Aerobic and Resistance Exercise Training

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
A Pilot Study of Combined Aerobic and Resistance Exercise Training in Metastatic Renal Cell Carcinoma
A regiszteradat frissítve
2024. április 4.